Deferasirox Tablet, Film Coated
Product Images NDC 72603-233

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 72603-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Deferasirox Fig1)

A bar chart showing changes in liver iron concentration and serum ferritin levels after oral suspension of Deferasirox tablets at doses from 5 to 30 mg/kg/day. The X-axis lists the dose in mg/kg/day, while the left Y-axis measures change in liver iron content (mg Fe/g dry weight) and the right Y-axis measures change in serum ferritin (mcg/L). Bars represent liver iron content changes (white) and serum ferritin changes (black) for each dose group.*

FDA Label Image

Package Label-principal Display Panel (90 mg (30 Tablet Bottle))

Label for Deferasirox Tablets 90 mg film-coated tablets, oral use. The label includes directions to dispense the medication guide separately, storage instructions, manufacturer and labeler information (Northstar Rx LLC), package count of 30 tablets, and a barcode.*

FDA Label Image

Package Label-principal Display Panel (180 mg (30 Tablet Bottle))

Label for Deferasirox Tablets 180 mg, oral film-coated tablets, in a package of 30 tablets. The label includes storage instructions, manufacturer details (Northstar Rx LLC, Memphis, TN, and APL Healthcare Limited, India), and a barcode. It advises pharmacists to dispense the medication guide separately and provides contact information for medication guides.*

FDA Label Image

Package Label-principal Display Panel (360 mg (30 Tablet Bottle))

Label for Deferasirox Tablets 360 mg, oral film-coated tablets, packaged in a bottle of 30 tablets. The label includes prescribing information such as dosage, storage instructions at controlled room temperature, and manufacturing details indicating production by APL Healthcare Limited in India for NorthStar Rx LLC. It also features a barcode and a coding area for serial number and expiry data.*

FDA Label Image

Chemical Structure (Deferasirox Str)

Chemical structure diagram showing the molecular structure of Deferasirox, the active ingredient in the product DEFERASIROX. The diagram includes linked aromatic rings and functional groups, illustrating the compound's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.